Learn More
Medchemexpress LLC Lyg-409 | 3053857-55-6 | 98.1% | 515.44 | 1 ML

Supplier: Medchemexpress LLC HY17095210MM/1ML
LYG-409 is an orally active degrader of GSPT1. It demonstrates excellent anti-acute myeloid leukemia and prostate cancer activity in vivo, with TGI of 94.34% and 104.49%, respectively. It inhibits KG-1 cells by degrading GSPT1, with an IC50 of 9.50 nM and a DC50 of 7.87 nM in vitro.
- Orally active degrader of GSPT1
- Excellent anti-acute myeloid leukemia and prostate cancer activity in vivo
- Inhibits KG-1 cells mediated by GSPT1 degradation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.